12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant movement in Thursday's after-market session. Notable gainers included Novo Integrated Sciences (NVOS), Processa Pharma (PCSA), Yield10 Bioscience (YTEN), 23andMe Holding (ME), Virpax Pharmaceuticals (VRPX), and Axcella Health (AXLA). On the other hand, Biodexa Pharmaceuticals (BDRX), MoonLake (MLTX), CervoMed (CRVO), Blue Water Biotech (BWV), Aravive (ARAV), and Sangamo Therapeutics (SGMO) saw their stock prices decrease.
August 31, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Axcella Health stock rose 12.81% to $0.26.
The rise in AXLA's stock price is likely to positively impact its short-term performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
23andMe Holding shares moved upwards by 15.45% to $1.27.
The upward movement in ME's share price is likely to have a positive impact on its short-term performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Novo Integrated Sciences shares increased by 48.6% to $0.21.
The significant increase in NVOS's share price is likely to have a positive impact on its short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Processa Pharma shares rose 23.66% to $0.39.
The rise in PCSA's share price is likely to positively impact its short-term performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Virpax Pharmaceuticals shares increased by 13.66% to $0.98.
The increase in VRPX's share price is likely to positively impact its short-term performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Yield10 Bioscience stock moved upwards by 20.44% to $0.43.
The upward movement in YTEN's stock price is likely to have a positive impact on its short-term performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Aravive stock fell 6.05% to $0.14.
The fall in ARAV's stock price is likely to negatively impact its short-term performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Biodexa Pharmaceuticals stock decreased by 14.9% to $6.8.
The decrease in BDRX's stock price is likely to negatively impact its short-term performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Blue Water Biotech stock decreased by 6.11% to $0.75.
The decrease in BWV's stock price is likely to negatively impact its short-term performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
CervoMed shares decreased by 6.42% to $5.54.
The decrease in CRVO's share price is likely to negatively impact its short-term performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
MoonLake stock decreased by 13.12% to $50.02.
The decrease in MLTX's stock price is likely to negatively impact its short-term performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Sangamo Therapeutics stock declined by 5.0% to $0.92.
The decline in SGMO's stock price is likely to negatively impact its short-term performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100